US sets to vote on controversial bill curbing China biotech investment; move will undermine global tech cooperation, hurt US firms: analysts

US sets to vote on controversial bill curbing China biotech investment; move will undermine global tech cooperation, hurt US firms: analysts

US congress Photo:VCG

The US Congress is set to vote, could happen this week, on the 2025 National Defense Authorization Act (NDAA), a “must-pass” annual defense bill that would restrict US outbound investment to China in sensitive sectors as…

Continue Reading